EUVIMEDEUVIMED entdecken
Crossref

Effects of D-Amino Acid Oxidase Inhibitor on the Extracellular D-Alanine Levels and the Efficacy of D-Alanine on Dizocilpine-Induced Prepulse Inhibition Deficits in Mice

Mao Horio, Yuko Fujita, Tamaki Ishima, Masaomi Iyo, Dana Ferraris, Takashi Tsukamoto, Kenji Hashimoto

The Open Clinical Chemistry Journal · 2009

DOI: 10.2174/1874241600902010016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Clinical Chemistry Journal, 2009. Verfasst von Mao Horio und 6 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

D-Alanine, one of D-amino acids present in the mammalian brain, is a selective and potent agonist at the Nmethyl-D-aspartate (NMDA) receptors.Like D-serine, D-alanine is reported to be effective in the treatment of schizophrenia.However, orally given D-alanine is metabolized substantially by D-amino acid oxidase (DAAO), diminishing its oral bioavailability.In this study, we studied the effects of oral D-alanine administration with or without the novel DAAO inhibitor, 5-chloro-benzo[d]isoxazol-3-ol (CBIO), on the extracellular D-alanine levels in the brain and on the prepulse inhibition (PPI) deficits after administration of the NMDA receptor antagonist dizocilpine.Co-administration of CBIO (30 mg/kg) with D-alanine (100 mg/kg), but not D-alanine (100 mg/kg) alone, significantly attenuated dizocilpine (0.1 mg/kg)-induced PPI deficits in mice.The in vivo microdialysis study of the conscious and free moving mice revealed that co-administration of CBIO (30 mg/kg) significantly increased extracellular levels of D-alanine in the frontal cortex after oral administration of D-alanine (100 mg/kg).These findings suggest that co-administration of CBIO can increase the bioavailability of D-alanine after oral administration of D-alanine, and that co-administration of CBIO can enhance the efficacy of D-alanine on dizocilpine-induced PPI deficits.Therefore, combination of D-alanine and a DAAO inhibitor such as CBIO offers new therapeutic potential for treatment of schizophrenia.

Zitieren

APA

Horio, M., Fujita, Y., Ishima, T., Iyo, M., Ferraris, D., Tsukamoto, T., & Hashimoto, K. (2009). Effects of D-Amino Acid Oxidase Inhibitor on the Extracellular D-Alanine Levels and the Efficacy of D-Alanine on Dizocilpine-Induced Prepulse Inhibition Deficits in Mice. The Open Clinical Chemistry Journal. https://doi.org/10.2174/1874241600902010016

Vancouver

Horio M, Fujita Y, Ishima T, Iyo M, Ferraris D, Tsukamoto T, et al. Effects of D-Amino Acid Oxidase Inhibitor on the Extracellular D-Alanine Levels and the Efficacy of D-Alanine on Dizocilpine-Induced Prepulse Inhibition Deficits in Mice. The Open Clinical Chemistry Journal. 2009. doi:10.2174/1874241600902010016

BibTeX
@article{Horio2009,
  author = {Horio, Mao and Fujita, Yuko and Ishima, Tamaki and Iyo, Masaomi and Ferraris, Dana and Tsukamoto, Takashi and Hashimoto, Kenji},
  title = {Effects of D-Amino Acid Oxidase Inhibitor on the Extracellular D-Alanine Levels and the Efficacy of D-Alanine on Dizocilpine-Induced Prepulse Inhibition Deficits in Mice},
  journal = {The Open Clinical Chemistry Journal},
  year = {2009},
  doi = {10.2174/1874241600902010016}
}
Kostenlos starten →